Straits Times Index
3,212.64 -6.36 (-0.20%) Nikkei
27,385.25 -34.36 (-0.13%) Hang Seng
19,915.68 -133.96 (-0.67%) FTSE 100
7,392.46 -107.14 (-1.43%) BTC-USD
28,145.95 +705.57 (+2.57%) CMC Crypto 200
612.28 -6.11 (-0.99%)
Organon & Co. (OGN)
| Previous close | 21.42 |
| Open | 21.39 |
| Bid | 21.18 x 1100 |
| Ask | 21.21 x 900 |
| Day's range | 20.96 - 21.41 |
| 52-week range | 20.96 - 39.09 |
| Volume | |
| Avg. volume | 2,205,011 |
| Market cap | 5.363B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 3.53 |
| EPS (TTM) | 5.97 |
| Earnings date | 16 Feb 2023 |
| Forward dividend & yield | 1.12 (3.77%) |
| Ex-dividend date | 10 Nov 2022 |
| 1y target est | 33.38 |
- Business Wire
Organon Launches "Her Plan is Her Power," a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist
JERSEY CITY, N.J., March 07, 2023--Organon Launches "Her Plan is Her Power," a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist
- CNW Group
Organon Canada receives the Women in Governance (WiG) Parity Certification SME, further demonstrating its commitment to gender parity in the workplace
Organon Canada, a subsidiary of Organon (NYSE: OGN), a global women's health company, is excited to share that in line with National Employee Appreciation Day on March 3, it has received the Women in Governance Parity Certification SME 1. The WiG Parity Certification SME is a national benchmark recognizing notable organizations for their ongoing efforts and commitments to gender parity in the workplace. Through integrating numerous programs and policies across the organization, Organon Canada ha
- CNW Group
Ahead of International Women's Day, Organon Canada Spotlights the Importance of Supporting Women's Equity While Highlighting the Cost of Not Investing in Their Health
For far too long, women's health issues have been underfunded, under researched and underserved. Leading up to International Women's Day on March 8, Organon Canada, a subsidiary of Organon (NYSE: OGN), a global women's health company, is challenging the healthcare ecosystem – along with academia, investors, policymakers, researchers and others – to consider the consequences of the growing health disparities that women are currently facing. In Canada, for the second consecutive year, the company
